MIT COVID-19 Challenge aims to 'hack' the coronavirus. View as Webpage
Transitioning to Virtual Healthcare. >>
 
 
 
Subscribe
 
 
 
April 8, 2020
 
cogs
 
 

Healthcare may be bracing for a major shortage of providers and services in the coming years, but even now the industry is straining to meet an ever-growing demand for personalized, patient-friendly care. Artificial intelligence has often been touted as the panacea for this challenge, with many pointing to finance, retail and other industries that have embraced automation.

But the consumerism adopted by other sectors doesn't always translate cleanly into healthcare, says Nagi Prabhu, chief product officer at Solutionreach. Whereas people may be ready to trust automation to handle their deliveries or even manage their finances, they still prefer the human touch when it comes to their personal health.

"That's what makes it challenging. There's an expectation that there's an interaction happening between the patient and provider, but the tools and services and resources that are available on the provider side are insufficient," Prabhu said during a HIMSS20 Virtual Webinar on AI and patient experience. "And that's what causing this big disconnect between what patients are seeing and wanting, compared to other industries where they have experienced it.

"You have got to be careful in terms of where you apply that AI, particularly in healthcare, because it must be in use cases that enrich human interaction. Human interaction is not replaceable," he said.

Despite the challenge, healthcare still has a number of "low-hanging fruit" use cases where automation can reduce the strain on healthcare staff without harming overall patient experience, Prabhu said. Chief among these patient communications, scheduling and patient feedback analysis, where the past decade's investments into natural language processing and machine learning have yielded tools that can handle straightforward requests at scale.

But even these implementations need to strike the balance between automation and a human touch, he warned. Take patient messaging, for example. AI can handle simple questions about appointment times or documentation. But if the patient asks a complex question about their symptoms or care plan, the tool should be able to gracefully hand off the conversation to a human staffer without major interruption.

"If you push the automation too far, from zero automation ... to 100% automation, there's going to be a disconnect because these tools aren't perfect," he said. "There needs to be a good balancing ... even in those use cases."

These types of challenges and automation strategies are already being considered, if not implemented, among major provider organizations, noted Kevin Pawl, senior director of patient access at Boston Children's Hospital.

"We've analyzed why patients and families call Boston Children's – over 2 million phone calls to our call centers each year – and about half are for non-scheduling matters," Pawl said during the virtual session. "Could we take our most valuable resource, our staff, and have them work on those most critical tasks? And could we use AI and automation to improve that experience and really have the right people in the right place at the right time?"

Pawl described a handful of AI-based programs his organization has deployed in recent years, such as Amazon Alexa skills for recording personal health information and flu and coronavirus tracking models to estimate community disease burden. In the patient experience space, he highlighted self-serve kiosks placed in several Boston Children's locations that guide patients through the check-in process – but that still encourage users to walk over to a live receptionist if they become confused or simply are more comfortable speaking to a human.

For these projects, Pawl said that Boston Children's needed to design their offerings around unavoidable hurdles like patients' fear of change, or even around broader system interoperability and security. For others looking to deploy similar AI tools for patient experience, he said that programs must keep in mind the need for iterative pilots, the value of walking providers and patients alike through each step of any new experience, and how the workflows and preferences of these individuals will shape their adoption of the new tools.

"These are the critical things that we think about as we are evaluating what we are going to use," he said. "Err on the side of caution."

Prabhu punctuated these warnings with his own emphasis on the data-driven design of the models themselves. These systems need to have enough historical information available to understand to answer the patient's questions, as well as the intelligence to know when a human is necessary.

"And, when it is not confident, how do you get a human being involved to respond – but at the same time from the patient perspective [the interaction appears] to continue?" he asked. "I think that is the key."

 
money pharma
 
 

The first three months of 2020 shattered all previous Q1 digital-health-funding records – amounting to a $3.1 billion in new investments – according to a new Rock Health report. Set against the backdrop of a global pandemic, this early funding success may not be indicative of a trend for the entire year. 

“Of course, this is not a post about historic funding levels – it is a story of healthy funding momentum cut off at the knees by a global pandemic,” authors of the Rock Health report wrote. “Though some of the economic blow will be tempered by demand for connected healthcare, we do not anticipate investment activity to keep pace with Q1 levels in the coming months.”

As alluded to in the quote, researchers at Rock Health don’t see this funding growth lasting. According to the organization’s research, 67% of health tech investors said that startups will have a harder time raising capital in 2020. 

The coronavirus pandemic has led to market volatility and has sent the U.S. down the trajectory for a recession. Rock Health predicts that access to capital as a whole will begin to tighten. However, access to private capital won’t contract as much as public capital. It notes that many private companies are sitting on dry powder – or funds that need to be invested, according to the report. 

However, some startups in the digital health space are innovating around the coronavirus. 

“Telemedicine, in particular, is deployed at the front lines of the pandemic. Although there have been some reports of growing pains as telemedicine providers adjust to a rapid uptick in demand, telemedicine startups are rapidly responding to the escalating health crisis."

WHY IT MATTERS 

As the coronavirus spreads across the world, there are still a lot of unknowns for the digital health world. With many working with private venture funds, the fall may not be as drastic from the onset. 

“Today, VCs are investing from a pool of money they raised yesterday,” Halle Tecco, founder of Rock Health and CEO of Natalist, wrote in an email to MobiHealthNews back in early March. “They may be more cautious about the business ideas they back (and if those companies can likely withstand a downturn), but I don't think we'll see any drastic decrease in funding this year.”

But there are still many unknowns after the dry powder is used. 

THE LARGER TREND 

Last year Rock Health reported a whopping $7.4 billion in digital health funding. While this was down slightly from 2018 (at $8.2 billion), it still marked a thriving industry.

Rock Health has been reporting on digital health funding since 2011, when it recorded $1.1 billion in funding deals. Since then, the industry has seen deals grow exponentially. The size of the deals has also grown significantly from $12 million in 2011 to $19.8 million in 2019. 

 
 
ADVERTISEMENT
Cisco
 
 
 
Spearheaded by the Information & eGovernment Authority, the new wristbands are part of the government’s effort in quickly tracing new cases of COVID-19, as well as keeping track of active cases.

Keep Reading >>
 
 
 
The new round was led by General Catalyst with participation from F-Prime Capital, Kickstart Seed Fund, Diōko Ventures and Jonathan Bush.

Keep Reading >>
 
 
 
The app requires no accessories or hardware other than the user’s smartphone.

Keep Reading >>
 
 
 
Also: FDA COVID-19 policy allows for remote use, digital modifications to ophthalmic devices; 23andMe launches genetics study to understand varying COVID-19 responses.

Keep Reading >>
 
 
 
A team at MIT creates a program that searches for ideas to fight COVID-19 via hackathons and virtual events.

Watch Now >>
 
 
 
How is the coronavirus pandemic affecting you?
 
 
By HIMSS Insights
 
There is a renaissance of wearables in digital healthcare. More and more of them, many AI-empowered, are finding their way into serious clinical trials, thus contributing to medical evidence and ultimately better patient care. But with data comes responsibility: The question of how to design a digital healthcare data space that respects the privacy of individuals while at the same time providing maximal medical benefit is more important than ever.

Download the ebook now >>
 
 
ADVERTISEMENT
HIMSS
 
Population & Public Health
 
Stay ahead of the curve
 
Just as it's doing with nearly every facet of society around the world, the COVID-19 crisis will radically transform approaches with patient engagement and pop health. From telemedicine and remote patient monitoring to AI and advanced analytics, healthcare was already in the midst of big changes in how it manages the health of patient populations.
 
 
 
 
 
2 Monument Sq., Ste 400 Portland, ME 04101
 
 
.